In addition, it has been demonstrated that high intrahepatic and circulating PCSK9 levels promote hepatic lipogenesis and lipid storage11,43, thus accelerating NAFLD pathogenesis. The gene discussed is PCSK9; the disease is metabolic dysfunction-associated steatotic liver disease.